Magnetic stents retain nanoparticle-bound antirestenotic drugs transported by lipid microbubbles

Pharmaceutical Research

Volumn 29, Issue 5, 2012, Pages 1295-1307

  Rathel T ^a   Mannell, H ^a   Pircher, J ^a   Gleich, B ^b   Pohl, U ^a   Krotz F ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Medical Clinic   (Germany)

Author keywords

Coronary stent; Magnetic targeting; Microbubble; Nanoparticles; Restenosis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FLUORESCENT DYE; LIPID; MAGNETIC NANOPARTICLE; NICKEL; RAPAMYCIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CIRCULATION TIME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG COATING; DRUG ELUTING STENT; DRUG TARGETING; FLOW RATE; IN VITRO STUDY; MAGNETIC FIELD; MATERIAL COATING; MICROBUBBLE; MOLECULAR WEIGHT; NONHUMAN; OUTCOME ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL; SWINE; TARGET CELL DESTRUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL PROLIFERATION; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; FLOW CYTOMETRY; FLUORESCENT DYES; GRAFT OCCLUSION, VASCULAR; MAGNETICS; MICROBUBBLES; SIROLIMUS; STENTS; SURFACE PROPERTIES; SWINE;

EID: 84862672569     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0643-y     Document Type: Article

References (26)

1. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496-501.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-95.
3. Daemen J, Serruys PW. Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation. 2007;116:316-28.
4. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56:1897-907.
5. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 2000;35:157-63.
6. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202.
7. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500-10.
8. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-24.
9. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986-94.
10. Pislaru SV, Harbuzariu A, Gulati R, Witt T, Sandhu NP, Simari RD, Sandhu GS. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol. 2006;48:1839-45.
11. Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, Ganta S, Adamo R, Amiji M, Friedman G, Levy RJ. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A. 2010;107:8346-51.
12. Mannell H, Hammitzsch A, Mettler R, Pohl U, Krotz F. Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt. Cell Signal. 2010;22:88-96.
13. Slevin M, Badimon L, Grau-Olivares M, Ramis M, Sendra J, Morrison M, Krupinski J. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Mol Biosyst. 2010;6:444-50.
14. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26.
15. Peng ZG, Hidajat K, Uddin MS. Adsorption of bovine serum albumin on nanosized magnetic particles. J Colloid Interface Sci. 2004;271:277-83.
16. Lindner JR, Song J, Jayaweera AR, Sklenar J, Kaul S. Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr. 2002;15:396-403.
17. Ferns GA, Avades TY. The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol. 2000;81:63-88.
18. Schiele TM, Krotz F, Klauss V. Vascular restenosis - striving for therapy. Expert Opin Pharmacother. 2004;5:2221-32.
19. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev. 2004;56:1291-314.
20. Braide M, Rasmussen H, Albrektsson A, Bagge U. Microvascular behavior and effects of sonazoid microbubbles in the cremaster muscle of rats after local administration. J Ultrasound Med. 2006;25:883-90.
21. Grishenkov D, Kari L, Brodin LK, Brismar TB, Paradossi G. In vitro contrast-enhanced ultrasound measurements of capillary microcirculation: comparison between polymer- and phospholipid-shelled microbubbles. Ultrasonics. 2011;51:40-8.
22. Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29:487-96.
23. Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, Yellen B, Friedman G, Levy RJ. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci U S A. 2008;105:698-703.
24. Holton A, Walsh E, Anayiotos A, Pohost G, Venugopalan R. Comparative MRI compatibility of 316 L stainless steel alloy and nickel-titanium alloy stents. J Cardiovasc Magn Reson. 2002;4:423-30.
25. Hug J, Nagel E, Bornstedt A, Schnackenburg B, Oswald H, Fleck E. Coronary arterial stents: safety and artifacts during MR imaging. Radiology. 2000;216:781-7.
26. Uppal R, Caravan P. Targeted probes for cardiovascular MR imaging. Future Med Chem. 2010;2(3):451-70.